Since serum ANGPTL2 leves links obesity with systemic insulin resistance and is positively associated with the development of T2DM (8), our results suggest that β-receptor activation helps to maintain the metabolic profile of MHO and prevent T2DM by decreasing serum ANGPTL2 levels. This evidence concerns the gene ANGPTL2 and obesity due to melanocortin 4 receptor deficiency.